Information Disclosure
Each research analyst of this material certifies that the views expressed in this research material accurately reflect the analyst’s personal views about the subject securities and listed corporations. None of the listed corporations reviewed or any third party has provided or agreed to provide any compensation or other benefits in connection with this material to any of the analyst(s).
| Company | Code | Disclosure |
| AIC Mines Limited | A1M | Argonaut is acting as Financial Adviser in relation to AIC Mines’ takeover offer for Demetallica Limited (DRM) in September 2022 and will receive fees commensurate with this service. Argonaut acted as Joint lead Manager to the Placement to raise up to $40M in October 2021 and received fees commensurate with that service. Argonaut holds or controls 1,501,804 A1M shares. |
| Agrimin Limited | AMN | Argonaut acts as Strategic Adviser to AMN and receives fees commensurate with that service. |
| Ausgold Ltd | AUC | Argonaut acted as Lead Manager to the Placement to raise $16M in March 2022 and received fees commensurate with this service. |
| Blackearth Minerals NL | BEM | Argonaut acted as Lead Manager to the Placement to raise $6.8M in January 2022 and received fees commensurate with this service. |
| Centaurus Metals Limited | CTM | Argonaut acted as Joint Lead Manager in respect of the Placement to raise $75M in January 2022 and received fees commensurate with this service. Argonaut holds or controls 161,638 CTM shares. |
| De Grey Mining Ltd | DEG | Argonaut Securities Pty Limited acted as Joint Lead Manager & Joint Bookrunner and Argonaut PCF Limited acted as Joint Underwriter to the $125M Placement announced 20 October 2021 and received fees commensurate with these services. |
| Family Zone Cyber Safety Limited |
FZO | Argonaut acted as Co-Manager to the Placement to raise $42M in May 2022 and received fees commensurate with this service. |
| Genesis Minerals Limited | GMD | Argonaut acted as Co-Manager in respect of the Placement to raise up to $100M announced in July 2022 and received fees commensurate with this service. Argonaut acted as Joint Financial Adviser in respect of the Placement to raise up to $16M announced in September 2021 and received GMD shares for this service. Argonaut holds or controls 1,918 GMD options exercisable on or before 17 December 2023. |
| Global Lithium Resources Ltd | GL1 | Argonaut acted as Joint Lead Manager in respect of the Placement to raise $29.9M in March 2022 and received fees commensurate with these services. Argonaut acted as Financial Adviser to GL1 with respect to the December 2021 acquisition of the 80% interest in the Manna Lithium Project from Breaker Resources and received fees commensurate with this service. Argonaut acted as Joint Lead Manager in respect of the Placement to raise $13.6M in October 2021 and received fees commensurate with this service. Argonaut holds or controls 5,506,886 shares and 4,493,114 GL1 options exercisable at $0.30 expiring 10 May 2025. |
| Gold Road Resources Limited | GOR | Argonaut acted as Financial Adviser and broker to GOR in October and November 2021 and received fees commensurate with these services. |
| K2Fly Ltd | K2F | Argonaut acted as Financial Adviser and Lead Manager to the Placement that raised $6.2M in April 2022 and received fees commensurate with this service. Argonaut holds or controls 2,265,625 K2F Options exercisable at $0.435 on or before 10 March 2024. |
| Lunnon Metals Ltd | LM8 | Argonaut acted as Joint Lead Manager in the Placement to raise $30M in April 2022 and received fees commensurate with this service. The Chair of Lunnon Metals Ltd (LM8), Mr Liam Twigger also holds roles with the Argonaut Group: Deputy Chair of Argonaut Limited and Executive Director, Corporate Finance. Mr Twigger is not involved in the creation of research material on LM8 in any way. The views expressed in LM8 research material accurately reflect the relevant analyst’s personal views about LM8. |
| Medallion Metals Limited | MM8 | Argonaut acted as Co-lead Manager in respect of the Placement to raise up to $4.7M announced in November 2021 and received fees commensurate with this service. Argonaut holds or controls 262,885 MM8 shares and 4M MM8 Options exercisable at $0.35 on or before 31 January 2023. |
| NexGen Energy Ltd | NXG | Argonaut holds 17,892 NXG shares. |
| Northern Star Resources Ltd | NST | Argonaut is acting as Financial Advisor to NST with respect to the sale of the Paulsens and Western Tanami Gold Operations announced in April 2022 and will receive fees commensurate with this service. |
| OreCorp Limited | ORR | Argonaut is acting as Joint Lead Manager in respect of the process to demerge OreCorp’s West Australian assets announced in January 2022 and will receive fees commensurate with this service. Argonaut acted as Co Lead Manager in respect of the Placement to raise $56M in June 2021 and received fees commensurate with this service. |
| Pantoro Limited | PNR | Argonaut acted as Joint Lead Manager to the Placement to raise $45M in March 2022 and received fees commensurate with this service. Argonaut holds or controls 5M PNR Shares. |
| Predictive Discovery Limited | PDI | Argonaut acted as Joint Lead Manager to the Placement to raise $50M in May 2022 and received fees commensurate with this service. |
| WIA Gold Limited | WIA | Argonaut acted as Lead Manager to the Placement to raise $4.6M in November 2021 for Tanga Resources Limited (TRL) and received fees commensurate with this service. Argonaut owns or controls 3,332,332 WIA shares and 1.5M WIA01 Options exercisable at $0.05 and 1.5M WIA02 exercisable at $0.10 on or before 30 September 2024. |
General Disclosure and Disclaimer
This research has been prepared by Argonaut Securities Pty Limited (ABN 72 108 330 650) (“ASPL”) for the use of the clients of ASPL and other related bodies corporate (the “Argonaut Group”) and must not be copied, either in whole or in part, or distributed to any other person. If you are not the intended recipient you must not use or disclose the information in this report in any way. ASPL is a holder of an Australian Financial Services License No. 274099 and is a Market Participant of the Australian Stock Exchange Limited.
Nothing in this report should be construed as personal financial product advice for the purposes of Section 766B of the Corporations Act 2001 (Cth). This report does not consider any of your objectives, financial situation or needs. The report may contain general financial product advice and you should therefore consider the appropriateness of the advice having regard to your situation. We recommend you obtain financial, legal and taxation advice before making any financial investment decision.
This research is based on information obtained from sources believed to be reliable and ASPL have made every effort to ensure the information in this report is accurate, but we do not make any representation or warranty that it is accurate, reliable, complete or up to date. The Argonaut Group accepts no obligation to correct or update the information or the opinions in it. Opinions expressed are subject to change without notice and accurately reflect the analyst(s)’ personal views at the time of writing. No member of the Argonaut Group or its respective employees, agents or consultants accepts any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research.
Nothing in this research shall be construed as a solicitation to buy or sell any financial product, or to engage in or refrain from engaging in any transaction. The Argonaut Group and/or its associates, including ASPL, officers or employees may have interests in the financial products or a relationship with the issuer of the financial products referred to in this report by acting in various roles including as investment banker, underwriter or dealer, holder of principal positions, broker, director or adviser. Further, they may buy or sell those securities as principal or agent, and as such may effect transactions which are not consistent with the recommendations (if any) in this research. The Argonaut Group and/or its associates, including ASPL, may receive fees, brokerage or commissions for acting in those capacities and the reader should assume that this is the case.
There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment.
The analyst(s) principally responsible for the preparation of this research may receive compensation based on ASPL’s overall revenues.
For U.S. Persons Only
This research report is a product of Argonaut Securities Pty Limited, which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account.
This report is intended for distribution by Argonaut Securities Pty Limited only to “Major Institutional Investors” as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor.
In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Argonaut Securities Pty Limited has entered into an agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. (“Marco Polo”). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer.
Copyright
© 2017. All rights reserved. No part of this document may be reproduced or distributed in any manner without the written permission of Argonaut Securities Pty Limited. Argonaut Securities Pty Limited specifically prohibits the re-distribution of this document, via the internet or otherwise, and accepts no liability whatsoever for the actions of third parties in this respect.
